Related Experiment Video
Updated: Dec 14, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Neonatal Mycoplasma and Ureaplasma Infections
Abstract:
Mycoplasma species (spp.) can be commensals or opportunistic pathogens of the urogenital tract, and they can be commonly isolated from amniotic fluid, placenta, and fetal/neonatal tissue or blood in mothers delivering prematurely or their preterm infants. Although the presence of Mycoplasma spp. has been associated with adverse maternal-fetal outcomes such as preterm birth and maternal chorioamnionitis, it is less clear whether vertical transmission to the neonate results in colonization or active infection/inflammation. Moreover, the presence of Mycoplasma spp. in neonatal blood, cerebrospinal fluid, or tissue has been variably associated with increased risk of neonatal comorbidities, especially bronchopulmonary dysplasia (BPD). Although the treatment of the mother or neonate with antibiotics is effective in eradicating ureaplasma, it is not clear that the treatment is effective in reducing the incidence of major morbidities of the preterm neonate (eg, BPD). In this article, we review the animal and clinical data for ureaplasma-related complications and treatment strategies. [Pediatr Ann. 2020;49(7):e305-e312.].
Insights
Mycoplasma species can cause preterm birth complications. Antibiotic treatment may eradicate ureaplasma but its effectiveness in preventing major preterm infant morbidities like bronchopulmonary dysplasia (BPD) requires further investigation.
Area of Science:
- Neonatal Medicine
- Microbiology
- Obstetrics
Background:
- Mycoplasma species are common in the urogenital tract and linked to preterm birth.
- Vertical transmission to neonates may cause colonization or infection.
- Association between Mycoplasma spp. and neonatal comorbidities, particularly bronchopulmonary dysplasia (BPD), is noted.
Purpose of the Study:
- To review animal and clinical data on ureaplasma-related complications.
- To examine the effectiveness of treatment strategies for Mycoplasma spp. in preterm infants.
Main Methods:
- Review of existing animal and clinical studies.
- Analysis of data on Mycoplasma spp. isolation and associated outcomes.
- Evaluation of antibiotic treatment efficacy.
Main Results:
- Mycoplasma spp. are frequently isolated from mothers delivering prematurely and their infants.
- The role of Mycoplasma spp. in neonatal infection versus colonization is not fully elucidated.
- Antibiotic eradication of ureaplasma is possible, but its impact on reducing major neonatal morbidities like BPD remains unclear.
Conclusions:
- Mycoplasma spp. are implicated in adverse maternal-fetal outcomes and neonatal complications.
- Further research is needed to clarify the impact of Mycoplasma spp. on neonatal health and the efficacy of treatments in preventing long-term morbidities.
Related Concept Videos
Bacterial Phylum Tenericutes
Acute Pyelonephritis I: Introduction
Bacterial Phylum Chlamydiae
Sexually Transmitted Infections
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection II: Pathophysiology

